• Tapinarof improves plaque psoriasis severity in phase 3 trials

    9 days ago - By Healio

    Tapinarof cream 1% met its secondary endpoints in two phase 3 trials for the treatment of plaque psoriasis, according to a poster presented at AAD VMX 2021.
    “We look at the primary endpoint, which is getting to clear or almost clear with a two-grade improvement, but there's also some important information that's included as a secondary outcome,” study co-author Linda Stein Gold, MD, told Healio.
    The two identically designed, multicenter, double-blind, vehicle-controlled, randomized trials randomly assigned patients 2:1 to receive tapinarof cream 1% or vehicle cream for
    Read more ...